30 Sept 2026, 09:56
Trading Halt / SuspensionMS
PARPARADIGM BIOPHARMACEUTICALS LIMITED..
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 09:51
Company UpdateMS
30 Sept 2026, 09:47
Company UpdateMS
28 Sept 2026, 09:45
OtherMS
24 Sept 2026, 15:40
Securities Administration—
24 Sept 2026, 15:25
Company UpdateMS
23 Sept 2026, 14:37
Company UpdateMS
23 Sept 2026, 09:01
Trading Halt / SuspensionMS
21 Sept 2026, 08:47
Trading Halt / SuspensionMS
18 Sept 2026, 11:13
Securities Administration—
15 Sept 2026, 09:46
Company Administration—
14 Sept 2026, 16:08
Securities Administration—
11 Sept 2026, 12:57
Securities Administration—
11 Sept 2026, 12:32
Securities Administration—
11 Sept 2026, 12:19
Securities AdministrationMS
11 Sept 2026, 11:05
Securities Administration—
3 Sept 2026, 09:27
Company Administration—
28 Aug 2026, 12:59
Company Administration—
28 Aug 2026, 12:47
Financial ResultsMS
25 Aug 2026, 18:03
Securities Administration—
13 Aug 2026, 09:33
Company Update—
30 July 2026, 16:56
Securities Administration—
30 July 2026, 09:55
Quarterly ReportsMS
27 July 2026, 08:17
Securities Administration—
22 July 2026, 08:18
Company UpdateMS
17 July 2026, 18:51
Securities Administration—
13 July 2026, 13:32
Securities Administration—
13 July 2026, 13:21
Securities Administration—
13 July 2026, 13:14
Securities AdministrationMS
1 July 2026, 17:52
Director Interests—
29 June 2026, 17:01
Securities Administration—
29 June 2026, 16:55
Securities Administration—
18 June 2026, 17:46
Director Interests—
18 June 2026, 17:46
Director Interests—
18 June 2026, 17:29
Securities Administration—
17 June 2026, 10:52
Securities Administration—
17 June 2026, 10:50
Securities Administration—
15 June 2026, 09:11
Company UpdateMS
11 June 2026, 18:29
Securities Administration—
11 June 2026, 12:56
Meetings & Governance—
5 June 2026, 18:34
Director Interests—
5 June 2026, 18:34
Director Interests—
4 June 2026, 08:20
Substantial Holders—
3 June 2026, 17:34
Securities Administration—
2 June 2026, 17:31
Securities Administration—
2 June 2026, 10:18
Securities Administration—
1 June 2026, 12:30
Securities Administration—
1 June 2026, 10:34
Capital RaisingMS
12 May 2026, 13:16
Meetings & Governance—
5 May 2026, 08:15
Substantial Holders—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:56 | Continuation of Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 30 Sept 2026, 09:51 | Appointment of Voluntary Administrators | Company Update | MS | 12008, 12015 | |
| 30 Sept 2026, 09:47 | Board Initiates Voluntary Administration | Company Update | MS | 12008, 12015 | |
| 28 Sept 2026, 09:45 | Continuation of Voluntary Suspension | Other | MS | 11003 | |
| 24 Sept 2026, 15:40 | Notification of cessation of securities - PAR | Securities Administration | — | 06027 | |
| 24 Sept 2026, 15:25 | Agreement to Return US$2M to Obsidian | Company Update | MS | 06009, 11001 | |
| 23 Sept 2026, 14:37 | Phase 3 Interim Result Below Continuation Threshold | Company Update | MS | 11001 | |
| 23 Sept 2026, 09:01 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 21 Sept 2026, 08:47 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 18 Sept 2026, 11:13 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 15 Sept 2026, 09:46 | Dr Daniel Furtner appointed Chief Medical Officer | Company Administration | — | 12008 | |
| 14 Sept 2026, 16:08 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 11 Sept 2026, 12:57 | Notice under Section 708A | Securities Administration | — | 06009, 06018 | |
| 11 Sept 2026, 12:32 | Notification regarding unquoted securities - PAR | Securities Administration | — | 06021 | |
| 11 Sept 2026, 12:19 | Drawdown of Tranche 4 under the Convertible Note Facility | Securities Administration | MS | 06009 | |
| 11 Sept 2026, 11:05 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 3 Sept 2026, 09:27 | Melbourne Investor Lunch | Company Administration | — | 12008 | |
| 28 Aug 2026, 12:59 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2026, 12:47 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 25 Aug 2026, 18:03 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 13 Aug 2026, 09:33 | 80% Safety Review Complete, September IA on Track | Company Update | — | 11001 | |
| 30 July 2026, 16:56 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 30 July 2026, 09:55 | June 2026 Quarterly Activities Report & Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 27 July 2026, 08:17 | Notification of cessation of securities - PAR | Securities Administration | — | 06027 | |
| 22 July 2026, 08:18 | Paradigm Receives $5.75m R&D Tax Incentive Refund | Company Update | MS | 11001 | |
| 17 July 2026, 18:51 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 13 July 2026, 13:32 | Notice under Section 708A | Securities Administration | — | 06018 | |
| 13 July 2026, 13:21 | Notification regarding unquoted securities - PAR | Securities Administration | — | 06021 | |
| 13 July 2026, 13:14 | Drawdown of Tranche 4 under the Convertible Note Facility | Securities Administration | MS | 06009 | |
| 1 July 2026, 17:52 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 29 June 2026, 17:01 | Notification of cessation of securities - PAR | Securities Administration | — | 06027 | |
| 29 June 2026, 16:55 | Notification of cessation of securities - PAR | Securities Administration | — | 06027 | |
| 18 June 2026, 17:46 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 18 June 2026, 17:46 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 18 June 2026, 17:29 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 17 June 2026, 10:52 | Listing of Options - Top 20 Holders and Distribution Reports | Securities Administration | — | 03002 | |
| 17 June 2026, 10:50 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 15 June 2026, 09:11 | PAR Completes Enrolment in Pivotal Phase 3 | Company Update | MS | 11001 | |
| 11 June 2026, 18:29 | Options Prospectus | Securities Administration | — | 06009, 06010 | |
| 11 June 2026, 12:56 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 5 June 2026, 18:34 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 5 June 2026, 18:34 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 June 2026, 08:20 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 3 June 2026, 17:34 | Notification of cessation of securities - PAR | Securities Administration | — | 06027 | |
| 2 June 2026, 17:31 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 2 June 2026, 10:18 | Application for quotation of securities - PAR | Securities Administration | — | 06020 | |
| 1 June 2026, 12:30 | Update - Proposed issue of securities - PAR | Securities Administration | — | 06013 | |
| 1 June 2026, 10:34 | Results of Share Purchase Plan | Capital Raising | MS | 06017 | |
| 12 May 2026, 13:16 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 5 May 2026, 08:15 | Becoming a substantial holder | Substantial Holders | — | 02001 |
1–50 of 112
1 / 3